SARS-CoV-2 Variants in COVID-19 Disease: A Focus on Disease Severity and Vaccine Immunity in Patients Admitted to the Emergency Department
- PMID: 36556222
- PMCID: PMC9783322
- DOI: 10.3390/jpm12122001
SARS-CoV-2 Variants in COVID-19 Disease: A Focus on Disease Severity and Vaccine Immunity in Patients Admitted to the Emergency Department
Abstract
Tracking SARS-CoV-2 variants along with vaccinations are fundamental for severe COVID-19 disease prevention. A study was performed that focused on 43 patients with the SARS-CoV-2 infection who were admitted to the Emergency Department. RT-PCR-positive nasopharyngeal samples were sequenced using the MiSeq II system for variant detection. The main reason for Emergency Department admission was COVID-19 (67%), followed by other causes (33%); 51% patients were unvaccinated or vaccinated with a single dose and 49% had completed the vaccination course with two or three doses. Among the vaccinated group, 38% were admitted for COVID-19, versus 94.5% of the unvaccinated group. After admission, 50% of the vaccinated group and 36% of the unvaccinated group were discharged and allowed to go home, and 80% of the unvaccinated had no major comorbidities; 63% needed hospital admission and 5% required a stay in the Intensive Care Unit. Of these, 37% were vaccinated with 3 doses, 11% with two doses, 4% with a single dose, and 48% were unvaccinated. The 70% of the vaccinated patients who were admitted to hospital presented major comorbidities versus 38% of the unvaccinated group. Two unvaccinated patients that needed intensive care had relevant comorbidities and died. Genome sequencing showed the circulation of three omicron and two pure sub-lineages of omicron, including 22 BA.1, 12 BA.1.1, and 7 BA.2. Data showed the SARS-CoV-2 national and international migration patterns and how vaccination was useful for severe COVID-19 disease prevention.
Keywords: COVID-19; SARS-CoV-2; VOC; omicron; sequencing; vaccination.
Conflict of interest statement
The authors declare no conflict of interest.
Figures


Similar articles
-
Clinical Characteristics and Outcomes Among Adults Hospitalized with Laboratory-Confirmed SARS-CoV-2 Infection During Periods of B.1.617.2 (Delta) and B.1.1.529 (Omicron) Variant Predominance - One Hospital, California, July 15-September 23, 2021, and December 21, 2021-January 27, 2022.MMWR Morb Mortal Wkly Rep. 2022 Feb 11;71(6):217-223. doi: 10.15585/mmwr.mm7106e2. MMWR Morb Mortal Wkly Rep. 2022. PMID: 35143466 Free PMC article.
-
SARS-CoV-2 Infections and Hospitalizations Among Persons Aged ≥16 Years, by Vaccination Status - Los Angeles County, California, May 1-July 25, 2021.MMWR Morb Mortal Wkly Rep. 2021 Aug 27;70(34):1170-1176. doi: 10.15585/mmwr.mm7034e5. MMWR Morb Mortal Wkly Rep. 2021. PMID: 34437525 Free PMC article.
-
COVID-19 Cases and Hospitalizations by COVID-19 Vaccination Status and Previous COVID-19 Diagnosis - California and New York, May-November 2021.MMWR Morb Mortal Wkly Rep. 2022 Jan 28;71(4):125-131. doi: 10.15585/mmwr.mm7104e1. MMWR Morb Mortal Wkly Rep. 2022. PMID: 35085222 Free PMC article.
-
Likelihood of infecting or getting infected with COVID-19 as a function of vaccination status, as investigated with a stochastic model for Aotearoa New Zealand for Delta and Omicron variants.N Z Med J. 2022 Apr 1;135:89-100. N Z Med J. 2022. PMID: 35728188
-
Infectious viral load in unvaccinated and vaccinated individuals infected with ancestral, Delta or Omicron SARS-CoV-2.Nat Med. 2022 Jul;28(7):1491-1500. doi: 10.1038/s41591-022-01816-0. Epub 2022 Apr 8. Nat Med. 2022. PMID: 35395151
Cited by
-
Investigating the trend of demographic changes, mortality, clinical and paraclinical findings of patients hospitalized in the Corona ward, before and after the start of general vaccination of COVID-19.BMC Infect Dis. 2024 May 13;24(1):488. doi: 10.1186/s12879-024-09279-z. BMC Infect Dis. 2024. PMID: 38741059 Free PMC article.
References
-
- WHO . SARS-CoV-2 Variants of Concern and Variants of Interest. World Health Organization; Geneva, Switzerland: 2021. [(accessed on 1 March 2021)]. Available online: https://www.who.int/en/activities/tracking-SARS-CoV-2-variants/
-
- CDC . SARS-CoV-2 Variant Classifications and Definitions. Centers for Disease Control and Prevention; Atlanta, GA, USA: 2021. [(accessed on 1 March 2021)]. Available online: https://www.cdc.gov/coronavirus/2019-ncov/variants/variant-info.html.
LinkOut - more resources
Full Text Sources
Miscellaneous